Skip to content
Home/Companies/Biotech/Calixar

Calixar

Biotech·France·Exited 2023·Held 11yr
Entry
2012
Hold
11yr
Exit
2023

Who owns Calixar?

Calixar was owned by XAnge through Capital 2 (2012 vintage) from 2012 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

XAnge
Investor
XAnge
Capital 2 · 2012 · VC

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from Capital 2

Other portfolio companies in the same fund.

Sensorberg
Sensorberg
Active
IndustrialsGermany· 2016
Chauffeur Privé
Chauffeur Privé
Exited 2018
MobilityFrance· 2015
to
Le Collectionist
Le Collectionist
Active
HospitalityFrance· 2015
Ledger
Ledger
Active
FintechFrance· 2015
Zenchef
Zenchef
Exited 2022
HospitalityFrance· 2015
to
AB Tasty
AB Tasty
Active
AdTechFrance· 2014

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Calixar

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Calixar.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue